Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13027884 | 0.90 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL27523422 | 0.87 | GAA (0.35) | TRPA1ATMGAAMAPTALDH1A1 | |
| SCHEMBL29022755 | 0.85 | HTR1B (0.35) | TRPA1ATMGAAMAPTALDH1A1 | |
| SCHEMBL28236979 | 0.84 | TRPA1 (0.35) | TRPA1ATMGAAMAPTALDH1A1 | |
| SCHEMBL109759 | 0.83 | TSHR (0.38) | GAAMAPTALDH1A1CYP3A4CYP1A2 | |
| SCHEMBL13027881 | 0.82 | CYP1A2 (0.35) | CYP1A2ELANECYP2A6 | |
| SCHEMBL20535490 | 0.82 | TRPA1 (0.34) | TRPA1ATMGAAMAPTALDH1A1 | |
| SCHEMBL13027138 | 0.82 | — | — | |
| SCHEMBL728385 | 0.81 | CYP1A2 (0.31) | GAAMAPTCYP1A2KDM4E | |
| SCHEMBL13027177 | 0.79 | CA12 (0.37) | GAAMAPTALDH1A1CYP3A4KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4488317-A1 | METHOD FOR PRODUCING CURABLE RESIN COMPOSITION | Kaneka Corporation (JP) | 2025-01-08 | — | — | EP | disclosed |
| CN-118556096-A | Method for producing curable resin composition | 株式会社钟化 | 2024-08-27 | — | — | CN | disclosed |
| EP-4410871-A1 | POLYMER AND CURABLE COMPOSITION | Kaneka Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| WO-2023162782-A1 | METHOD FOR PRODUCING CURABLE RESIN COMPOSITION | 株式会社カネカ | 2023-08-31 | — | — | WO | disclosed |
| CN-108473684-B | Process for producing siloxane polymer | 东丽精细化工株式会社 | 2023-05-12 | — | — | CN | disclosed |
| WO-2023053988-A1 | POLYMER AND CURABLE COMPOSITION | 株式会社カネカ | 2023-04-06 | — | — | WO | disclosed |
| US-10647821-B2 | Production process for silicone polymer | TORAY FINE CHEMICALS CO., LTD. (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20190023848-A1 | PRODUCTION PROCESS FOR SILICONE POLYMER | TORAY FINE CHEMICALS CO., LTD. (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-2275427-B1 | Ruthenium-diamine complex and methods for producing optically active compounds | TAKASAGO PERFUMERY CO LTD (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-8404879-B2 | Ruthenium-diamine complex and methods for producing optically active compounds | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| EP-2275427-A1 | Ruthenium-diamine complex and methods for producing optically active compounds | Takasago International Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20110009646-A1 | RUTHENIUM-DIAMINE COMPLEX AND METHODS FOR PRODUCING OPTICALLY ACTIVE COMPOUNDS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-0985510-B1 | ARTICLE WITH UNEVEN SURFACE, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION THEREFOR | NIPPON SHEET GLASS CO LTD (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-20020064666-A1 | Article having uneven surface, production process for the article, and composition for the process | SHINMO KATSUHIDE (JP) | 2002-05-30 | — | — | US | disclosed |
| US-6361718-B1 | MOLDING POLYSILOXANE FILMS FROM SILANOLS AND SILANE HALIDES; HEAT RESISTANT AND NONCRACKING; USED TO MANUFACTURE OPTICAL RECORDING MEDIA | NIPPON SHEET GLASS CO., LTD. (JP) | 2002-03-26 | — | — | US | disclosed |
| EP-1142682-A1 | METHOD FOR PRODUCING ARTICLE HAVING PREDETERMINED SURFACE SHAPE, AND OPTICAL WAVEGUIDE ELEMENT | Nippon Sheet Glass Co., Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-0985510-A1 | ARTICLE WITH ROUGH SURFACE, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION THEREFOR | Nippon Sheet Glass Co., Ltd. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0258788-B1 | PROCESS FOR PREPARING PROPYLENE HOMO- AND COPOLYMERS BY MEANS OF A ZIEGLER-NATTA CATALYTIC SYSTEM | BASF Aktiengesellschaft (DE) | 1990-05-30 | — | — | EP | disclosed |
| EP-0258788-A1 | Process for preparing propylene homo- and copolymers by means of a Ziegler-Natta catalytic system | BASF Aktiengesellschaft (DE) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009646-A1 | RUTHENIUM-DIAMINE COMPLEX AND METHODS FOR PRODUCING OPTICALLY ACTIVE COMPOUNDS | ADH5, AOC1, ADH1A | TRPA1 1431/4885ATM 2758/4885GAA 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.